000 | 01649 a2200481 4500 | ||
---|---|---|---|
005 | 20250517125943.0 | ||
264 | 0 | _c20170320 | |
008 | 201703s 0 0 eng d | ||
022 | _a1473-5644 | ||
024 | 7 |
_a10.1099/jmm.0.000401 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYilmaz, Gürdal | |
245 | 0 | 0 |
_aIndividualized antibiotic therapy in patients with ventilator-associated pneumonia. _h[electronic resource] |
260 |
_bJournal of medical microbiology _cJan 2017 |
||
300 |
_a78-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcinetobacter baumannii _xdrug effects |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
650 | 0 | 4 |
_aCalcitonin _xblood |
650 | 0 | 4 |
_aEnterobacter cloacae _xdrug effects |
650 | 0 | 4 |
_aEscherichia coli _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFever _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntensive Care Units |
650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOxygen _xblood |
650 | 0 | 4 |
_aPneumonia, Ventilator-Associated _xdiagnosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
650 | 0 | 4 |
_aSerratia marcescens _xdrug effects |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
700 | 1 | _aSalyan, Sedat | |
700 | 1 | _aAksoy, Firdevs | |
700 | 1 | _aKöksal, İftihar | |
773 | 0 |
_tJournal of medical microbiology _gvol. 66 _gno. 1 _gp. 78-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1099/jmm.0.000401 _zAvailable from publisher's website |
999 |
_c26661102 _d26661102 |